Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Quotient LtdQTNT · Entity 116378 | Director | July 31, 2022 | August 02, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Quotient Ltd
Report date July 31, 2022 · Filed August 02, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 131,999 |
Reported balance
After 2022-07-31 transaction · row 2
1 source rowRow 2 · 2022-07-31 · Exercise / conversion · Acquired 13,538 · Balance 131,999 F1: Restricted Stock Units convert into ordinary shares on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,868 |
Reported balance
After 2022-07-31 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2022-07-31 · Exercise / conversion · Disposed 10,870 · Balance 10,868 F1: Restricted Stock Units convert into ordinary shares on a one-for-one basis. F11: On October 31, 2021, the Reporting Person was granted 43,478 restricted stock units, of which 32,574 have vested and have converted into ordinary shares. The remaining 10,868 restricted stock units will vest on October 31, 2022. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,668 |
Reported balance
After 2022-07-31 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2022-07-31 · Exercise / conversion · Disposed 2,668 · Balance 2,668 F1: Restricted Stock Units convert into ordinary shares on a one-for-one basis. F12: On October 31, 2021, the Reporting Person was granted 10,672 restricted stock units, of which 8,004 have vested and have converted into ordinary shares. The remaining 2,668 restricted stock units will vest on October 31, 2022. |
| Ordinary SharesSEC Table I · non-derivative | IndirectSee footnote | 11,995,740 |
Reported balance
Holding disclosure · report date 2022-07-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 11,995,740 F2: Includes 10,913,091 ordinary shares held of record by Galen V LP, 931,945 ordinary shares held by Galen International V LP, and 150,704 ordinary shares held of record by Galen Management, LLC. Mr. Shroff is a managing director of Galen Management, LLC, and shares voting and dispositive power over the securities held by Galen V LP, Galen International V LP and Galen Management, LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein. |
| Ordinary Shares Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.62 · Expires 2025-10-31 | Direct | 7,505 |
Reported balance
Holding disclosure · report date 2022-07-31 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 7,505 F3: All 7,505 options have vested and remain exercisable. |
| Ordinary Shares Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.00 · Expires 2024-04-29 | Direct | 5,000 |
Reported balance
Holding disclosure · report date 2022-07-31 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 5,000 F4: All 5,000 options have vested and remain exercisable. |
| Ordinary Shares Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.95 · Expires 2024-10-31 | Direct | 5,025 |
Reported balance
Holding disclosure · report date 2022-07-31 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 5,025 F5: All 5,025 options have vested and remain exercisable. |
| Ordinary Shares Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.73 · Expires 2026-10-31 | Direct | 8,726 |
Reported balance
Holding disclosure · report date 2022-07-31 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 8,726 F6: All 8,726 options have vested and remain exercisable. |
| Ordinary Shares Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.21 · Expires 2027-10-31 | Direct | 9,597 |
Reported balance
Holding disclosure · report date 2022-07-31 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 9,597 F7: All 9,597 options have vested and remain exercisable. |
| Ordinary Shares Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.41 · Expires 2028-10-31 | Direct | 6,240 |
Reported balance
Holding disclosure · report date 2022-07-31 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 6,240 F8: All 6,240 options have vested and remain exercisable. |
| Ordinary Shares Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.78 · Expires 2029-10-31 | Direct | 8,158 |
Reported balance
Holding disclosure · report date 2022-07-31 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 8,158 F9: 2,719 options vested on October 31, 2021 and remain exercisable, and the remaining 2,720 options will vest on October 31, 2022. |
| Ordinary Shares Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.55 · Expires 2030-10-31 | Direct | 13,611 |
Reported balance
Holding disclosure · report date 2022-07-31 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 13,611 F10: All 13,611 options have vested and remain exercisable. |
| Ordinary Shares Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.53 · Expires 2031-10-31 | Direct | 24,040 |
Reported balance
Holding disclosure · report date 2022-07-31 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 24,040 F13: The options vest and become exercisable on October 31, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units convert into ordinary shares on a one-for-one basis.
F2: Includes 10,913,091 ordinary shares held of record by Galen V LP, 931,945 ordinary shares held by Galen International V LP, and 150,704 ordinary shares held of record by Galen Management, LLC. Mr. Shroff is a managing director of Galen Management, LLC, and shares voting and dispositive power over the securities held by Galen V LP, Galen International V LP and Galen Management, LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
F3: All 7,505 options have vested and remain exercisable.
F4: All 5,000 options have vested and remain exercisable.
F5: All 5,025 options have vested and remain exercisable.
F6: All 8,726 options have vested and remain exercisable.
F7: All 9,597 options have vested and remain exercisable.
F8: All 6,240 options have vested and remain exercisable.
F9: 2,719 options vested on October 31, 2021 and remain exercisable, and the remaining 2,720 options will vest on October 31, 2022.
F10: All 13,611 options have vested and remain exercisable.
F11: On October 31, 2021, the Reporting Person was granted 43,478 restricted stock units, of which 32,574 have vested and have converted into ordinary shares. The remaining 10,868 restricted stock units will vest on October 31, 2022.
F12: On October 31, 2021, the Reporting Person was granted 10,672 restricted stock units, of which 8,004 have vested and have converted into ordinary shares. The remaining 2,668 restricted stock units will vest on October 31, 2022.
F13: The options vest and become exercisable on October 31, 2022.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TACTILE SYSTEMS TECHNOLOGY INC
Report date May 09, 2017 · Filed May 12, 2017
Section 16 reporting ended · disclosed 2017-05-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,494 |
Reported balance
After 2017-05-09 transaction · row 1
1 source rowRow 1 · 2017-05-09 · Grant · Acquired 170 · Balance 6,494 F1: On May 9, 2017, the reporting person was granted 170 restricted stock units ("RSUs") in lieu of a prorated cash compensation amount of $3,694.44 for the amount of time the reporting person served as director during the second quarter. The RSUs are 100% immediately vested and may only be settled in shares of common stock on a one-for-one basis. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 4,743,635 |
Reported balance
Holding disclosure · report date 2017-05-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 4,743,635 F2: Includes 4,370,430 shares held of record by Galen Partners V, L.P. ("Galen V"), and 373,205 shares held of record by Galen Partners International V, L.P. ("Galen International V"). F3: Galen Partners V, L.L.C. serves as the sole general partner of Galen V and Galen International V and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Each of the Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 62,056 |
Reported balance
Holding disclosure · report date 2017-05-09 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 62,056 F4: The shares are held of record by Galen Management, LLC ("Galen Management"). |
Filing footnotes · ownership attribution and instrument terms
F1: On May 9, 2017, the reporting person was granted 170 restricted stock units ("RSUs") in lieu of a prorated cash compensation amount of $3,694.44 for the amount of time the reporting person served as director during the second quarter. The RSUs are 100% immediately vested and may only be settled in shares of common stock on a one-for-one basis.
F2: Includes 4,370,430 shares held of record by Galen Partners V, L.P. ("Galen V"), and 373,205 shares held of record by Galen Partners International V, L.P. ("Galen International V").
F3: Galen Partners V, L.L.C. serves as the sole general partner of Galen V and Galen International V and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Each of the Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
F4: The shares are held of record by Galen Management, LLC ("Galen Management").
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2019 Filed Feb 4, 2019 16:05 UTC | Quotient Ltd QTNT · Entity 116378 | Exercise / conversionRestricted Stock Units · Derivative | 4,680 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-002438 · doc4.xml · derivative · entry 9 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,041 Underlying: Ordinary Shares · 4,680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert into ordinary shares on a one-for-one basis. F9 · derivative.exercise_date: On October 31, 2018, the Reporting Person was granted 18,721 restricted stock units, of which 4,680 have vested and have been exercised. The remaining 14,041 restricted stock units will vest in three equal installments on April 30, 2019, July 30, 2019 and October 31, 2019. F9 · derivative.expiration_date: On October 31, 2018, the Reporting Person was granted 18,721 restricted stock units, of which 4,680 have vested and have been exercised. The remaining 14,041 restricted stock units will vest in three equal installments on April 30, 2019, July 30, 2019 and October 31, 2019. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 16:05 UTC | Quotient Ltd QTNT · Entity 116378 | Exercise / conversionOrdinary Shares | 4,680 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-002438 · doc4.xml · nonDerivative · entry 2 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units convert into ordinary shares on a one-for-one basis. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 16:35 UTC | Quotient Ltd QTNT · Entity 116378 | GrantOrdinary Share Option (Right to Buy) · Derivative | 6,240 | $0.00 Strike: $6.41 | $0.00 |
DisclosureSEC source: 0000899243-18-028032 · doc4.xml · derivative · entry 11 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,240 Underlying: Ordinary Shares · 6,240 shares Expires 2028-10-31 F11 · derivative.exercise_date: The options vest and become exercisable in three equal annual installments beginning October 31, 2019. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 16:35 UTC | Quotient Ltd QTNT · Entity 116378 | GrantRestricted Stock Units · Derivative | 18,721 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-028032 · doc4.xml · derivative · entry 10 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,721 Underlying: Ordinary Shares · 18,721 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert into ordinary shares on a one-for-one basis. F10 · derivative.exercise_date: On October 31, 2018, the Reporting Person was granted 18,721 restricted stock units, vesting in four equal installments on January 31, 2019, April 30, 2019, July 30, 2019 and October 31, 2019. F10 · derivative.expiration_date: On October 31, 2018, the Reporting Person was granted 18,721 restricted stock units, vesting in four equal installments on January 31, 2019, April 30, 2019, July 30, 2019 and October 31, 2019. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 16:35 UTC | Quotient Ltd QTNT · Entity 116378 | Exercise / conversionRestricted Stock Units · Derivative | 2,879 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-028032 · doc4.xml · derivative · entry 9 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,879 Underlying: Ordinary Shares · 2,879 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert into ordinary shares on a one-for-one basis. F9 · derivative.exercise_date: On October 31, 2017, the Reporting Person was granted 5,758 restricted stock units, of which 2,879 have vested and have been exercised. The remaining 2,879 restricted stock units will vest on October 31, 2019. F9 · derivative.expiration_date: On October 31, 2017, the Reporting Person was granted 5,758 restricted stock units, of which 2,879 have vested and have been exercised. The remaining 2,879 restricted stock units will vest on October 31, 2019. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 16:35 UTC | Quotient Ltd QTNT · Entity 116378 | Exercise / conversionRestricted Stock Units · Derivative | 2,618 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-028032 · doc4.xml · derivative · entry 7 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,618 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert into ordinary shares on a one-for-one basis. F7 · derivative.exercise_date: On October 31, 2016, the Reporting Person was granted 5,236 restricted stock units, all of which have vested and have been exercised. F7 · derivative.expiration_date: On October 31, 2016, the Reporting Person was granted 5,236 restricted stock units, all of which have vested and have been exercised. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 16:35 UTC | Quotient Ltd QTNT · Entity 116378 | Exercise / conversionOrdinary Shares | 5,497 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-028032 · doc4.xml · nonDerivative · entry 2 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units convert into ordinary shares on a one-for-one basis. Read SEC document |
| July 23, 2018 Filed Jul 25, 2018 16:54 UTC | Quotient Ltd QTNT · Entity 116378 | OtherWarrant (Right to Buy) · Derivative | 419,728 | Not disclosed Strike: $5.80 | Not disclosed |
DisclosureSEC source: 0001209191-18-043910 · doc4.xml · derivative · entry 3 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Ordinary Shares · 419,728 shares Expires 2018-07-31 F4 · price: Each warrant represented a right to purchase ordinary shares at an exercise price of $5.80 per share. F3 · derivative.exercise_date: The warrants are immediately exercisable. F5 · ownership.nature: Prior to the exercise Galen V held 386,695 warrants to purchase ordinary shares and Galen International V held 33,033 warrants to purchase ordinary shares. Each of Galen V and Galen International V exercised their warrants in full. Read SEC document |
| July 23, 2018 Filed Jul 25, 2018 16:54 UTC | Quotient Ltd QTNT · Entity 116378 | OtherOrdinary Shares | 419,728 | $5.80 | $2,434,422.40 |
DisclosureSEC source: 0001209191-18-043910 · doc4.xml · nonDerivative · entry 1 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,329,074 F1 · shares: The ordinary shares were acquired upon the exercise of warrants to purchase ordinary shares. Galen Partners V LP ("Galen V") acquired 386,695 ordinary shares and Galen Partners International V LP ("Galen International V") acquired 33,033 ordinary shares. F2 · ownership.nature: Includes 6,613,590 ordinary shares held of record by Galen V, 564,780 ordinary shares held of record by Galen International V and 150,704 ordinary shares held of record by Galen Management, LLC (collectively, "Galen Partners"). John Wilkerson, David W. Jahns and Zubeen Shroff exercise voting, investment and dispositive rights over the securities held of record by Galen Partners. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 18:23 UTC | Quotient Ltd QTNT · Entity 116378 | GrantRestricted Stock Units · Derivative | 5,758 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-025296 · doc4.xml · derivative · entry 10 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,758 Underlying: Ordinary Shares · 5,758 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units covert into ordinary shares on a one-for-one basis. F11 · derivative.exercise_date: On October 31, 2017, the Reporting Person was granted 5,758 restricted stock units, vesting in two equal installments on October 31, 2018 and October 31, 2019. F11 · derivative.expiration_date: On October 31, 2017, the Reporting Person was granted 5,758 restricted stock units, vesting in two equal installments on October 31, 2018 and October 31, 2019. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 18:23 UTC | Quotient Ltd QTNT · Entity 116378 | GrantOrdinary Share Option (Right to Buy) · Derivative | 9,597 | $0.00 Strike: $5.21 | $0.00 |
DisclosureSEC source: 0000899243-17-025296 · doc4.xml · derivative · entry 9 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,597 Underlying: Ordinary Shares · 9,597 shares Expires 2027-10-31 F10 · derivative.exercise_date: The options vest and become exercisable in three equal annual installments beginning October 31, 2018. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 18:23 UTC | Quotient Ltd QTNT · Entity 116378 | Exercise / conversionRestricted Stock Units · Derivative | 2,618 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-025296 · doc4.xml · derivative · entry 7 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,618 Underlying: Ordinary Shares · 2,618 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units covert into ordinary shares on a one-for-one basis. F7 · derivative.exercise_date: On October 31, 2016, the Reporting Person was granted 5,236 restricted stock units, of which 2,618 have vested and have been exercised. The remaining 2,618 restricted stock units will vest on October 31, 2018. F7 · derivative.expiration_date: On October 31, 2016, the Reporting Person was granted 5,236 restricted stock units, of which 2,618 have vested and have been exercised. The remaining 2,618 restricted stock units will vest on October 31, 2018. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 18:23 UTC | Quotient Ltd QTNT · Entity 116378 | Exercise / conversionOrdinary Shares | 2,618 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-17-025296 · doc4.xml · nonDerivative · entry 2 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units covert into ordinary shares on a one-for-one basis. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 18:05 UTC | Quotient Ltd QTNT · Entity 116378 | GrantWarrants to purchase Ordinary Shares · Derivative | 419,728 | $0.13 Strike: $5.80 | $52,466.00 |
DisclosureSEC source: 0001209191-17-058364 · doc4.xml · derivative · entry 2 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 419,728 Underlying: Ordinary Shares · 419,728 shares Expires 2018-07-31 F3 · shares: Galen V LP acquired a warrant to purchase 386,695 ordinary shares and Galen International V acquired a warrant to purchase 33,033 ordinary shares. F4 · derivative.exercise_date: The warrants are immediately exercisable. F5 · ownership.nature: Includes a warrant to purchase 386,695 ordinary shares held of record by Galen V and a warrant to purchase 33,033 ordinary shares held of record by Galen International V. Mr. Shroff is a managing director of Galen Management, LLC, and shares voting and dispositive power over the securities held of record by Galen V, Galen International V and Galen Management, LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 18:05 UTC | Quotient Ltd QTNT · Entity 116378 | GrantOrdinary Shares | 419,728 | $4.64 | $1,947,537.92 |
DisclosureSEC source: 0001209191-17-058364 · doc4.xml · nonDerivative · entry 1 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 6,909,346 F1 · shares: Galen Partners V LP ("Galen V") acquired 386,695 ordinary shares and Galen Partners International V LP ("Galen International V") acquired 33,033 ordinary shares. F2 · ownership.nature: Includes 6,226,895 ordinary shares held of record by Galen V, 531,747 ordinary shares held of record by Galen International V and 150,704 ordinary shares held of record by Galen Management, LLC. Mr. Shroff is a managing director of Galen Management, LLC, and shares voting and dispositive power over the securities held of record by Galen V, Galen International V and Galen Management, LLC. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his pecuniary interest therein. Read SEC document |
| May 09, 2017 Filed May 12, 2017 01:05 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 170 | $21.68 | $3,685.60 |
DisclosureSEC source: 0001437749-17-008818 · rdgdoc.xml · nonDerivative · entry 1 SHROFF ZUBEEN · CIK 0001056630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,494 F1 · shares: On May 9, 2017, the reporting person was granted 170 restricted stock units ("RSUs") in lieu of a prorated cash compensation amount of $3,694.44 for the amount of time the reporting person served as director during the second quarter. The RSUs are 100% immediately vested and may only be settled in shares of common stock on a one-for-one basis. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 21:00 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 461 | $18.95 | $8,735.95 |
DisclosureSEC source: 0001437749-17-006049 · rdgdoc.xml · nonDerivative · entry 1 SHROFF ZUBEEN · CIK 0001056630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,324 F1 · shares: On March 31, 2017, the reporting person was granted 461 restricted stock units ("RSUs") in lieu of cash compensation of $8,750.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and may only be settled in shares of common stock on a one-for-one basis. F1 · price: On March 31, 2017, the reporting person was granted 461 restricted stock units ("RSUs") in lieu of cash compensation of $8,750.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and may only be settled in shares of common stock on a one-for-one basis. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 21:07 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 533 | $16.41 | $8,746.53 |
DisclosureSEC source: 0001437749-17-000149 · rdgdoc.xml · nonDerivative · entry 1 SHROFF ZUBEEN · CIK 0001056630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,863 F1 · shares: On December 30, 2016, the reporting person was granted 533 restricted stock units ("RSUs") in lieu of cash compensation of $8,750.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and may only be settled in shares of common stock on a one-for-one basis. F1 · price: On December 30, 2016, the reporting person was granted 533 restricted stock units ("RSUs") in lieu of cash compensation of $8,750.00 pursuant to Tactile Systems Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and may only be settled in shares of common stock on a one-for-one basis. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 20:49 UTC | Quotient Ltd QTNT · Entity 116378 | GrantRestricted Stock Units · Derivative | 5,236 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-16-032684 · doc4.xml · derivative · entry 6 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,236 Underlying: Ordinary Shares · 5,236 shares Expires not disclosed F6 · derivative.exercise_price: Restricted Stock Units convert into ordinary shares on a one-for-one basis. F7 · derivative.exercise_date: On October 31, 2016, the reporting person was granted 5,236 restricted stock units, vesting in two equal installments on October 31, 2017 and October 31, 2018. F7 · derivative.expiration_date: On October 31, 2016, the reporting person was granted 5,236 restricted stock units, vesting in two equal installments on October 31, 2017 and October 31, 2018. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 20:49 UTC | Quotient Ltd QTNT · Entity 116378 | GrantOrdinary Share Option (Right to Buy) · Derivative | 8,726 | $0.00 Strike: $5.73 | $0.00 |
DisclosureSEC source: 0000899243-16-032684 · doc4.xml · derivative · entry 5 SHROFF ZUBEEN · CIK 0001056630 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,726 Underlying: Ordinary Shares · 8,726 shares Expires 2026-10-31 F5 · derivative.exercise_date: The options vest and become exercisable in three equal annual installments beginning October 31, 2017. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 20:37 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-16-039392 · rdgdoc.xml · nonDerivative · entry 1 SHROFF ZUBEEN · CIK 0001056630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,330 F1 · shares: On September 30, 2016, the reporting person was granted 330 restricted stock units ("RSUs") in lieu of cash compensation of $6,182.00 pursuant to Tactile System's Technology, Inc.'s Non-Employee Director Compensation Policy. The RSUs are 100% immediately vested and may only be settled in shares of common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.